HUBEI PROVINCE, CHINA -- (MARKET WIRE) -- May 24, 2007 -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB: BPMA), a China-based pharmaceutical company producing conventional and Traditional Chinese Medicines, as well as Genedicine®, the world's first commercialized gene therapy medicine for the treatment of cancer, will host a conference call on Wednesday, May 30, 2007 to review first quarter 2007 earnings results. The conference call is scheduled for 9:00 am, Eastern Time. To participate in the call, please dial:
